Each monograph includes:
Millions of Indonesians rely on generic drugs that were first approved under the FI Edisi 3 standards. For quality control labs conducting retrospective analysis or stability studies, referring back to the original monograph is legally required.
Over 500 monographs are included in this edition. Examples include: farmakope indonesia edisi 3 pdf
Each monograph includes:
Subject: Pharmaceutical Sciences / Pharmacopoeia Objective: To provide an overview, access guidance, and practical usage tips for the Farmakope Indonesia Edisi III. Each monograph includes: Millions of Indonesians rely on
As of 2025, the Indonesian government has not released an official "E- Paper" searchable PDF for Edisi 3. The policy is to encourage migration to FI Edisi 6 and the Indonesian Herbal Pharmacopoeia. The legacy edition is kept for historical reference and legal continuity for older drug licenses (i.e., drugs that never underwent re-evaluation).
If you absolutely need the PDF for a regulatory audit, your only legal recourse is to scan a verified library copy. As of 2025, the Indonesian government has not
The Farmakope Indonesia Edisi 3 was officially published by the Ministry of Health of the Republic of Indonesia as a national standard for pharmaceutical ingredients, finished drug products, and traditional medicines. This edition marked a significant transition from the previous versions (Edisi 1 and 2) by:
While newer editions (Edisi 4, 5, and 6) exist, many older drugs, generics, and research studies still legally reference the methods and standards of FI Edisi 3.
Understanding the structure helps you navigate the PDF once you find it. FI Edisi 3 is divided into several distinct sections: